Earnings Reports — November 04, 2026 — Midday Update — Last 24 Hours (Pacific Time)
Executive Summary
The last 24 hours delivered a broadly constructive earnings season, with the majority of reporting companies beating on at least one metric and a meaningful number posting double beats. Standout reactions include AMD surging ~4% on strong AI chip demand, Arista Networks jumping 6%+ on upbeat guidance, Duolingo soaring 12%, and Novo Nordisk jumping 6% on raised obesity-drug outlook — while Datadog tumbled despite a beat, Skyworks fell 12% on weak guidance, Amdocs plunged 44% on a T-Mobile dispute, and Taboola slid 15% on a revenue miss. Key themes: AI infrastructure demand remains robust, healthcare/pharma results are mixed, and guidance quality is increasingly the market's primary focus over headline beats.
Earnings Performance Breakdown
|
| Category | Count | % of Classified |
|---|---|---|
| 🟢 Double Beat (EPS + Revenue both beat) | ~95 | ~55% |
| ⚪ Mixed (beat one, missed other / in-line) | ~52 | ~30% |
| 🔴 Double Miss (EPS + Revenue both missed) | ~26 | ~15% |
Total classified results: ~173
(Note: Several headlines cover the same company from different angles; duplicates were consolidated. Preview-only articles — the majority of the 599 headlines — are excluded from classification.)
Notable Earnings Reports
🟢 Advanced Micro Devices (AMD) — Beat
- EPS: $2.09, beat by $0.15; revenue topped estimates
- Stock jumped ~4% after hours
- Strong AI chip demand drove the outperformance; Q4 revenue guidance also topped expectations
🔴 Amdocs (DOX) — In-Line Results, Catastrophic Guidance
- EPS matched at $1.98; revenue in line
- Stock plunged 44% on weak guidance amid a T-Mobile dispute
- A rare case where matching estimates meant almost nothing against a forward-looking shock
🟢 Arista Networks (ANET) — Double Beat
- EPS: $1.20, beat by $0.12; revenue topped estimates
- Shares jumped 6%+ after hours on strong Q3 results and upbeat guidance
- Networking demand tied to AI data center buildout remains a key tailwind
🟢 CVS Health (CVS) — Double Beat
- EPS: $2.09, beat by $0.44; revenue topped estimates
- Beat estimates and raised guidance amid announced split plans
- One of the largest EPS beats among large-cap names in this cycle
🟢 Novo Nordisk (NVO) — Raised Outlook (European)
- Shares jumped ~6% after lifting 2026 outlook on obesity-drug demand; Q3 obesity sales jumped 22%
- ADR EPS technically missed by $3.74 vs. estimates — ambiguity likely reflects currency/reporting differences
- The raised guidance and volume growth were the market's focus
🔴 Skyworks Solutions (SWKS) — Guidance Shock
- EPS: $1.28, beat by $0.01; revenue topped estimates
- Shares fell 12.4% after hours on weak forward guidance
- Apple iPhone demand concerns weighed heavily on the outlook
🟢 Insulet (PODD) — Double Beat
- EPS: $1.99, beat by $0.40; revenue topped estimates
- No specific stock reaction mentioned, but the $0.40 beat is among the largest magnitude surprises in medtech
🟢 Stanley Black & Decker (SWK) — Double Beat + Guidance Raise
- EPS: $2.31, beat by $0.75; revenue in line
- Stock gained on the beat and raised guidance
- One of the largest EPS surprise magnitudes among industrials
🟢 Duolingo (DUOL) — Revenue Beat, EPS Slight Miss
- EPS: $0.54, missed by $0.03; revenue topped estimates
- Stock soared 12% on accelerating user growth — market focused on top-line momentum
- A clear case of the market rewarding growth over near-term profitability
🔴 Datadog (DDOG) — Beat but Stock Tumbled
- EPS: $0.81, beat by $0.17; revenue topped estimates
- Stock fell despite the beat — guidance or valuation concerns implied
- Highlights the "sell the news" dynamic for high-multiple tech names
Sector Analysis
🟢 Technology / AI Infrastructure — Strong
AMD, Arista Networks, Kyndryl, CDW, GlobalFoundries, and MACOM (previewed) all beat or are expected to benefit from AI-driven demand. The AI data center theme is the clearest cross-sector tailwind, touching semiconductors, networking, and cloud infrastructure.
🟢 Healthcare / Pharma — Mostly Positive
Amgen, Charles River Labs, Zimmer Biomet (raised guidance), BioCryst, LivaNova, and Insulet all beat. Novo Nordisk's obesity-drug momentum is a standout global theme. However, United Therapeutics missed EPS by $0.50, and Harmony Biosciences missed by $0.30.
🟢 Financials / Insurance — Broadly Positive
CVS, AIG, Prudential, Assurant (beat by $1.81, raised guidance), Jack Henry, and UWM Holdings all beat. Mortgage insurer MGIC and specialty insurers face rate headwinds (previewed).
🟢 Energy / Commodities — Mixed-to-Positive
Suncor surged 158% in adjusted earnings; Ovintiv more than doubled profit; Matador, Talos Energy, and SM Energy all beat. Mosaic missed on a larger-than-expected loss. Peabody Energy missed by $0.28.
🔴 Consumer / Retail — Patchy
Haverty Furniture missed on both lines; Acushnet missed estimates (though stock rose on guidance); AdvanSix missed by $0.52. Wayfair beat but shares fell 3%. Dine Brands missed EPS by $0.17.
🔴 Building Materials — Weak
Owens Corning missed by $0.62 on EPS and revenue, stock fell 4%. Martin Marietta missed EPS by $0.70. Eagle Materials beat revenue but missed earnings. A consistent theme of softer demand and margin pressure.
🟢 Industrials — Broadly Positive
Emerson, Trex, Avient (raised guidance), Ralliant (raised guidance, +5%), Timken (+3%), and Primoris (surged on strong guidance) all beat. The industrial sector showed resilience.
🟡 Media / Ad Tech — Mixed
New York Times beat; Taboola fell 15% on revenue miss and weak guidance; Criteo missed EPS by $0.15 despite a revenue beat. MSG Entertainment beat on a record concert quarter.
Biggest Movers
| Stock | Move | Direction | Catalyst |
|---|---|---|---|
| Amdocs (DOX) | -44% | 🔴 | Weak guidance, T-Mobile dispute |
| Duolingo (DUOL) | +12% | 🟢 | Revenue beat, accelerating user growth |
| Nobia (ST:NOBI) | -19% | 🔴 | Q3 adjusted profit fell, cash flow turned negative |
| Skyworks (SWKS) | -12.4% | 🔴 | Weak guidance despite Q4 beat |
| Novo Nordisk | +6% (pared to +4.2%) | 🟢 | Raised 2026 outlook, obesity drug demand |
| Arista Networks (ANET) | +6% | 🟢 | Strong Q3 + upbeat guidance |
| AMD (AMD) | +4% | 🟢 | AI chip demand, Q4 guidance beat |
| Flywire (FLYW) | +11% | 🟢 | Earnings beat, raised guidance |
| Datadog (DDOG) | Tumbled (% not specified) | 🔴 | Beat estimates but sold off — guidance concerns implied |
| Taboola (TBLA) | -15% | 🔴 | Revenue miss, weak guidance |
| Block (XYZ) | +6% | 🟢 | Cash App strength, raised guidance |
| Pandora | +7% | 🟢 | Q3 like-for-like sales beat, tariff refund |
| Continental | +6% | 🟢 | Q3 beat, raised margin and cash flow outlook |
| Heidelberg Materials | +8% | 🟢 | Q3 profit beat, raised cost-savings target |
| Siltronic | +8% | 🟢 | Q3 beat, raised 2026 outlook |
| Vishay Intertechnology (VSH) | +12% | 🟢 | Strong Q3 beat |
| Shoals Technologies (SHLS) | +5% | 🟢 | Beat estimates |
| Ralliant (RAL) | +5% | 🟢 | Strong Q3 beat, raised guidance |
Earnings Sentiment
Net Sentiment: 🟢 Cautiously Bullish
The beat rate comfortably exceeds the miss rate, with roughly 55% of reporting companies posting double beats and only ~15% double misses — a healthy ratio that suggests corporate earnings remain resilient despite macro uncertainty.
Guidance is the key differentiator: companies raising full-year outlooks (Zimmer Biomet, Avient, Assurant, Jack Henry, Novo Nordisk, Ralliant, Primoris) were rewarded, while those cutting or disappointing on guidance (Amdocs, Skyworks, ESAB, Taboola, ATS Corporation) were punished severely regardless of headline beats. This dynamic — where the beat matters less than what comes next — is the defining feature of this earnings cycle.
Stock reactions skew positive in aggregate, but the dispersion is wide. High-multiple tech and growth names face a tougher bar, while value-oriented industrials, energy, and financials are being rewarded more consistently for execution.
Market Implications
AI Demand Is Real and Broadening. AMD's strong AI chip results and Arista Networks' upbeat guidance confirm that AI infrastructure spending is not slowing. This is filtering through to semiconductors, networking, data center REITs (Iron Mountain previewed), and power utilities (DTE Energy, Black Hills, Evergy all previewed with data center angles). Investors should watch whether this translates into sustained capex cycles or a near-term air pocket.
Guidance Quality Is the New EPS Beat. The market's brutal treatment of Amdocs (-44%), Skyworks (-12%), and Datadog (tumbled despite a beat) underscores that investors are laser-focused on forward visibility. Companies that beat but guide cautiously are being sold; companies that raise guidance are being rewarded with outsized moves. This suggests the market is pricing in a more uncertain macro backdrop for 2027.
Consumer and Building Materials Are Flashing Yellow. Owens Corning, Haverty Furniture, AdvanSix, Martin Marietta, and Acushnet all missed or disappointed, pointing to continued softness in housing-adjacent and discretionary spending. Meanwhile, fast-casual and restaurant names (McDonald's beat, CAVA previewed) show more resilience at the lower price point — a bifurcation worth watching as the consumer spending picture evolves.
👉 Vlad's Key Takeaways
- 🟢 AMD (AMD) — AI chip demand drove a clean beat and strong guidance; the AI infrastructure trade remains intact heading into Q4.
- 🔴 Amdocs (DOX) — A 44% single-day plunge on guidance alone is a stark reminder that matching estimates means nothing if the forward outlook collapses; T-Mobile dispute is a material risk.
- 🟢 Arista Networks (ANET) — 6%+ after-hours gain on Q3 beat + strong guidance; networking is a direct AI beneficiary and the results back it up.
- 🔴 Skyworks (SWKS) — Fell 12% despite a Q4 beat; Apple iPhone demand concerns are real and the market is pricing in a weaker cycle ahead.
- 🟢 CVS Health (CVS) — Beat by $0.44 and raised guidance amid split plans; execution is improving and the restructuring thesis is gaining credibility.
- 🟢 Novo Nordisk — Raised 2026 outlook with obesity drug sales up 22%; GLP-1 demand remains the most powerful secular growth story in global pharma.
- 🟢 Insulet (PODD) — $0.40 EPS beat is one of the largest magnitude surprises in medtech; diabetes device demand is holding up well.
- 🔴 Datadog (DDOG) — Beat on EPS and revenue but stock tumbled; high-multiple cloud names face a "prove it on guidance" bar that is increasingly difficult to clear.
- 🟢 Duolingo (DUOL) — Soared 12% on accelerating user growth; the market is rewarding top-line momentum over near-term EPS precision.
- 🔴 Taboola (TBLA) — Fell 15% on revenue miss and weak guidance; ad tech outside the major platforms continues to struggle for pricing power.
- 🟢 Stanley Black & Decker (SWK) — Beat by $0.75 and raised guidance; industrial execution is improving and the turnaround is gaining traction.
- 🔴 Owens Corning (OC) — Missed on both EPS and revenue, stock fell 4%; building materials demand remains under pressure from the housing slowdown.
- 🟢 Suncor Energy (SU) — Adjusted earnings surged 158%; stronger oil prices and refining margins are a powerful combination for integrated energy names.
- 🟢 Block (XYZ) — Jumped 6%+ on Cash App strength and raised guidance; fintech execution is improving after a difficult stretch.
- 🟢 Assurant (AIZ) — Beat by $1.81 and raised guidance; specialty insurance is one of the cleaner earnings stories this cycle.
- 🔴 Nobia (ST:NOBI) — Fell 19% as adjusted profit dropped and cash flow turned negative; European consumer-facing names face a tough demand environment.
- 🟢 Vishay Intertechnology (VSH) — Surged 12% on a strong Q3 beat; electronic components demand is recovering, potentially signaling a broader semiconductor cycle upturn.
- 🟢 Flywire (FLYW) — Soared 11% on beat and raised guidance; cross-border payments in education and healthcare verticals are outperforming.
- 🟡 McDonald's (MCD) — Beat EPS by $0.19 but revenue fell short; comparable sales beat expectations, suggesting value-focused consumers are still showing up even as ticket sizes moderate.
- 🔴 Building Materials Sector — Owens Corning, Martin Marietta, and Eagle Materials all disappointed on earnings; housing-adjacent demand weakness is a consistent theme that investors in this space cannot ignore.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/